NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking of Eve™, a critical congenital heart disease (CCHD) newborn screening application, for the Rad-97™ Pulse ...
Patient and Public Health Groups Invited to Apply for Up to 100 Shield Colorectal Cancer Blood Tests to Support Community Screening Events and Educational Outreach in March PALO ALTO, Calif., Feb. 12, ...
As the founder of a property management company that has an eviction rate of less than 1%, I know firsthand how the success of your rental property hinges on finding trustworthy and reliable tenants ...
In this webinar, Dr. Johann Stojko, experienced biophysicist at Novalix, will present integrated workflows that combine ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced Dual SET ® Pulse Oximetry for Root ®, a highly versatile patient monitoring and connectivity hub. The first application ...
A recently released prospective analysis of the first eight years of the Johns Hopkins Medicine-led Zero TB in Kids program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results